Ditchcarbon
  • Contact
  1. Organizations
  2. Cuu Long Pharmaceutical Joint Stock Company
Public Profile
Pharmaceutical Preparation Manufacturing
VN
updated 24 days ago

Cuu Long Pharmaceutical Joint Stock Company Sustainability Profile

Company website

Cuu Long Pharmaceutical Joint Stock Company, commonly referred to as Cuu Long Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 2001, the company has made significant strides in the production and distribution of high-quality pharmaceutical products across various regions in Vietnam. Cuu Long Pharma focuses on the development of generic medicines, herbal products, and dietary supplements, setting itself apart with a commitment to innovation and quality. The company has achieved notable milestones, including certifications from international quality standards, which bolster its reputation in the market. With a strong market position, Cuu Long Pharmaceutical is recognised for its extensive product range and dedication to improving healthcare outcomes. Its unique offerings and strategic operational approach have solidified its status as a trusted name in the Vietnamese pharmaceutical landscape.

DitchCarbon Score

How does Cuu Long Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Cuu Long Pharmaceutical Joint Stock Company's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Cuu Long Pharmaceutical Joint Stock Company's reported carbon emissions

Cuu Long Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cuu Long Pharmaceutical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company appears to be in the early stages of addressing its environmental impact within the pharmaceutical industry context.

How Carbon Intensive is Cuu Long Pharmaceutical Joint Stock Company's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cuu Long Pharmaceutical Joint Stock Company's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Cuu Long Pharmaceutical Joint Stock Company's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cuu Long Pharmaceutical Joint Stock Company is in VN, which we do not have grid emissions data for.

Cuu Long Pharmaceutical Joint Stock Company's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Cuu Long Pharmaceutical Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Cuu Long Pharmaceutical Joint Stock Company's Emissions with Industry Peers

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Fresenius Kabi Aktiengesellschaft

DE
•
Real estate services (70)
Updated 3 months ago

MEKOPHAR Chemical Pharmaceutical Joint Stock Company

VN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Lamdong Pharmaceutical Joint Stock Company

VN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Pfizer Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251215.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy